(Total Views: 183)
Posted On: 03/21/2022 8:56:18 AM
Post# of 24

$CRTX News Article - Cortexyme Provides New GAIN Trial Data at AD/PD 2022 Demonstrating Potential Benefit of Lysine Gingipain Inhibition in Mild to Moderate Alzheimer's Population https://marketwirenews.com/news-releases/cort...18448.html


My Twitter: WhyteStocks